Pharma Mar (OTCMKTS:PHMMF) Reaches New 52-Week High – What’s Next?

Pharma Mar, S.A. (OTCMKTS:PHMMF) hit a new 52-week high on Wednesday . The company traded as high as $75.00 and last traded at $75.00, with a volume of 0 shares changing hands. The stock had previously closed at $75.00.

Wall Street Analysts Forecast Growth

Separately, Chardan Capital raised Pharma Mar to a “strong-buy” rating in a research note on Thursday, August 1st.

Pharma Mar Stock Performance

The company’s fifty day moving average is $66.55 and its 200 day moving average is $46.00. The company has a current ratio of 2.55, a quick ratio of 2.01 and a debt-to-equity ratio of 0.14.

About Pharma Mar

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.